New Jersey Business NJ

Bristol Myers Squibb agrees to buy Orbital Therapeutics to bolster cell therapy portfolio

Return On Information New Jersey

Oct 10, 2025

Bristol Myers Squibb agreed to buy Orbital Therapeutics Oct. 10 for $1.5 billion in a cash transaction that strengthens Bristol Myers's cell therapy portfolio, expanding CAR T-cell…

Read the full story at Return On Information New Jersey

Bristol Myers Squibb agrees to buy Orbital Therapeutics to bolster cell therapy portfolio

More from New Jersey Business

Statement: Sherrill administration should have delayed New Jersey's new independent contractor regulations

New Report Says N.J. Needs More Affordable Homes for Sale, Not Just Buyer Assistance

100,000 Square Foot Expansion Breaks Ground at Liberty Science Center

Panoramic Manhattan Views and a Private Terrace Define This Avora Residence

New Jersey cannot afford to send mixed signals to business

Team Moza Debuts Casa One, Featuring 196 Rental Residences in Journal Square

Princeton Community Housing to Build Affordable Apartments on Former DPW Site

All-Affordable 113-Unit Development Moves Forward in Wayne